Skip to main content

Nontuberculous Mycobacterial Infections

  • Chapter
  • First Online:
Emerging Ocular Infections

Part of the book series: Essentials in Ophthalmology ((ESSENTIALS))

  • 204 Accesses

Abstract

Non-tuberculous mycobacteria (NTM) encompass a broad spectrum of organisms consisting of over 190 species. These organisms typically cause disease through environmental exposure, most commonly following trauma or procedures. The ocular manifestations of NTM are manifold, but due to the propensity of these organisms to form biofilms, the most notable manifestation has been multifocal chorioretinitis following cardiopulmonary bypass using heater-cooler units contaminated by M. chimaera. Treatment depends on the type of organism and its rate of growth. While some slow-growing NTM are susceptible to the four-drug therapeutic regimen used for tuberculosis (TB) treatment, the length of therapy is significantly longer than for TB. Some subtypes of NTM may be resistant to tuberculous therapy. The hardy nature of NTM may also create challenges in finding antibiotic regimens that can adequately penetrate the biofilms formed by these organisms.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Daley CL. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Eur Respir J. 2020;56

    Google Scholar 

  2. Koh W-J. Nontuberculous Mycobacteria—overview. Microbiol Spectr. 2017:5. https://doi.org/10.1128/microbiolspec.TNMI7-0024-2016.

  3. Falkinham JO. Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease. Emerg Infect Dis. 2011;17:419–24. https://doi.org/10.3201/eid1703.101510.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Honda JR, Knight V, Chan ED. Pathogenesis and risk factors for nontuberculous mycobacterial lung disease. Clin Chest Med. 2015;36:1–11. https://doi.org/10.1016/j.ccm.2014.10.001.

    Article  PubMed  Google Scholar 

  5. Falkinham JO. Challenges of NTM drug development. Front Microbiol. 2018;9:1613. https://doi.org/10.3389/fmicb.2018.01613.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367–416. https://doi.org/10.1164/rccm.200604-571ST.

    Article  CAS  PubMed  Google Scholar 

  7. Shah M, Relhan N, Kuriyan AE, Davis JL, Albini TA, Pathengay A, et al. Endophthalmitis caused by nontuberculous mycobacterium: clinical features, antimicrobial susceptibilities, and treatment outcomes. Am J Ophthalmol. 2016;168:150–6. https://doi.org/10.1016/j.ajo.2016.03.035.

    Article  PubMed  Google Scholar 

  8. Huang SC, Soong HK, Chang JS, Liang YS. Non-tuberculous mycobacterial keratitis: a study of 22 cases. Br J Ophthalmol. 1996;80:962–8. https://doi.org/10.1136/bjo.80.11.962.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Chandra NS, Torres MF, Winthrop KL, Bruckner DA, Heidemann DG, Calvet HM, et al. Cluster of Mycobacterium Chelonae keratitis cases following laser in-situ keratomileusis. Am J Ophthalmol. 2001;132:819–30. https://doi.org/10.1016/S0002-9394(01)01267-3.

    Article  CAS  PubMed  Google Scholar 

  10. Moorthy RS, Valluri S, Rao NA. Nontuberculous mycobacterial ocular and adnexal infections. Surv Ophthalmol. 2012;57:202–35. https://doi.org/10.1016/j.survophthal.2011.10.006.

    Article  PubMed  Google Scholar 

  11. Girgis DO, Karp CL, Miller D. Ocular infections caused by non-tuberculous mycobacteria: update on epidemiology and management: ocular mycobacterial infections. Clin Exp Ophthalmol. 2012;40:467–75. https://doi.org/10.1111/j.1442-9071.2011.02679.x.

    Article  PubMed  Google Scholar 

  12. Holland SP, Pulido JS, Miller D, Ellis B, Alfonso E, Scott M, et al. Biofilm and scleral buckle-associated infections. Ophthalmology. 1991;98:933–8. https://doi.org/10.1016/S0161-6420(91)32199-7.

    Article  CAS  PubMed  Google Scholar 

  13. Chang V, Karp CL, Yoo SH, Ide T, Budenz DL, Kovach JL, et al. Mycobacterium abscessus endophthalmitis after Descemetʼs stripping with automated endothelial keratoplasty. Cornea. 2010;29:586–9. https://doi.org/10.1097/ICO.0b013e3181bd44b4.

    Article  PubMed  Google Scholar 

  14. Hsu C-R, Chen J-T, Yeh K-M, Hsu C-K, Tai M-C, Chen Y-J, et al. A cluster of nontuberculous mycobacterial endophthalmitis (NTME) cases after cataract surgery: clinical features and treatment outcomes. Eye. 2018;32:1504–11. https://doi.org/10.1038/s41433-018-0108-1.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Ambler JS, Meisler DM, Zakov ZN, Hall GS, Spech TJ. Endogenous mycobacterium chelonae endophthalmitis. Am J Ophthalmol. 1989;108:338–9. https://doi.org/10.1016/0002-9394(89)90136-0.

    Article  CAS  PubMed  Google Scholar 

  16. Williamson D, Howden B, Stinear T. Mycobacterium chimaera spread from heating and cooling units in heart surgery. N Engl J Med. 2017;376:600–2. https://doi.org/10.1056/NEJMc1612023.

    Article  PubMed  Google Scholar 

  17. Zweifel SA, Mihic-Probst D, Curcio CA, Barthelmes D, Thielken A, Keller PM, et al. Clinical and histopathologic ocular findings in disseminated Mycobacterium chimaera infection after cardiothoracic surgery. Ophthalmology. 2017;124:178–88. https://doi.org/10.1016/j.ophtha.2016.09.032.

    Article  PubMed  Google Scholar 

  18. Holt M, Kasperbauer S. Management of extrapulmonary nontuberculous mycobacterial infections. Semin Respir Crit Care Med. 2018;39:399–410. https://doi.org/10.1055/s-0038-1651490.

    Article  PubMed  Google Scholar 

  19. Chu H-S, Chang S-C, Shen EP, Hu F-R. Nontuberculous mycobacterial ocular infections—comparing the clinical and microbiological characteristics between mycobacterium abscessus and Mycobacterium massiliense. PLoS One. 2015;10:e0116236. https://doi.org/10.1371/journal.pone.0116236.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Mauriello JA, Atypical Mycobacterial Study Group. Atypical mycobacterial infection of the periocular region after periocular and facial surgery. Ophthal Plast Reconstr Surg. 2003;19:182–8. https://doi.org/10.1097/01.iop.0000064994.09803.cb.

    Article  PubMed  Google Scholar 

  21. Oz O, Lee DH, Smetana SM, Akduman L. A case of infected scleral buckle with mycobacterium chelonae associated with chronic intraocular inflammation. Ocul Immunol Inflamm. 2004;12:65–7. https://doi.org/10.1076/ocii.12.1.65.28069.

    Article  PubMed  Google Scholar 

  22. Pope J, Sternberg P, McLane NJ, Potts DW, Stulting RD. Mycobacterium chelonae scleral abscess after removal of a scleral buckle. Am J Ophthalmol. 1989;107:557–8. https://doi.org/10.1016/0002-9394(89)90511-4.

    Article  PubMed  Google Scholar 

  23. Margo CE. Mycobacterium chelonae conjunctivitis and scleritis following vitrectomy. Arch Ophthalmol. 2000;118:1125. https://doi.org/10.1001/archopht.118.8.1125.

    Article  CAS  PubMed  Google Scholar 

  24. Smiddy WE, Miller D, Flynn HW. Scleral buckle infections due to atypical mycobacteria. Retina. 1991;11:394–8. https://doi.org/10.1097/00006982-199111040-00005.

    Article  CAS  PubMed  Google Scholar 

  25. Sossi N. Mycobacterium gordonae keratitis after penetrating keratoplasty. Arch Ophthalmol. 1991;109:1064. https://doi.org/10.1001/archopht.1991.01080080022011.

    Article  CAS  PubMed  Google Scholar 

  26. Lalitha P, Rathinam SR, Srinivasan M. Ocular infections due to non-tuberculous mycobacteria. Indian J Med Microbiol. 2004;22(4):231–7. https://pubmed-ncbi-nlm-nih-gov.ccmain.ohionet.org/17642744/.

  27. Matieli LCV, De Freitas D, Sampaio J, Moraes NSB, Yu MCZ, Hofling-Lima AL. Mycobacterium abscessus endophthalmitis: treatment dilemma and review of the literature. Retina. 2006;26:826–9. https://doi.org/10.1097/01.iae.0000244276.80716.96.

    Article  PubMed  Google Scholar 

  28. Ramaswamy A. Postoperative mycobacterium chelonae endophthalmitis after extracapsular cataract extraction and posterior chamber intraocular lens implantation. Ophthalmology. 2000;107:1283–6. https://doi.org/10.1016/S0161-6420(00)00162-7.

    Article  CAS  PubMed  Google Scholar 

  29. Roussel TJ, Stern WH, Goodman DF, Whitcher JP. Postoperative mycobacterial endophthalmitis. Am J Ophthalmol. 1989;107:403–6. https://doi.org/10.1016/0002-9394(89)90664-8.

    Article  CAS  PubMed  Google Scholar 

  30. Cohen JI, Saragas SJ. Endophthalmitis due to Mycobacterium avium in a patient with AIDS. Ann Ophthalmol. 1990;22:47–51.

    CAS  PubMed  Google Scholar 

  31. Rosenbaum PS. Atypical mycobacterial panophthalmitis seen with iris nodules. Arch Ophthalmol. 1998;116:1524. https://doi.org/10.1001/archopht.116.11.1524.

    Article  CAS  PubMed  Google Scholar 

  32. Morinelli EN, Dugel PU, Riffenburgh R, Rao NA. Infectious multifocal choroiditis in patients with acquired immune deficiency syndrome. Ophthalmology. 1993;100:1014–21. https://doi.org/10.1016/S0161-6420(93)31543-5.

    Article  CAS  PubMed  Google Scholar 

  33. Wassermann HE. Avian tuberculosis endophthalmitis. Arch Ophthalmol. 1973;89:321–3. https://doi.org/10.1001/archopht.1973.01000040323013.

    Article  CAS  PubMed  Google Scholar 

  34. Bhikoo R, Bevan R, Sims J. Multifocal choroiditis with panuveitis in a patient with disseminated mycobacterium avium complex. Retin Cases Brief Rep. 2013;7:155–7. https://doi.org/10.1097/ICB.0b013e3182790ef9.

    Article  PubMed  Google Scholar 

  35. Kuznetcova TI, Sauty A, Herbort CP. Uveitis with occult choroiditis due to mycobacterium kansasii: limitations of interferon-gamma release assay (IGRA) tests (case report and mini-review on ocular non-tuberculous mycobacteria and IGRA cross-reactivity). Int Ophthalmol. 2012;32:499–506. https://doi.org/10.1007/s10792-012-9588-3.

    Article  PubMed  Google Scholar 

  36. Böni C, Al-Sheikh M, Hasse B, Eberhard R, Kohler P, Hasler P, et al. Multimodal imaging of choroidal lesions in disseminated mycobacterium chimaera infection after cardiothoracic surgery. Retina. 2019;39:452–64. https://doi.org/10.1097/IAE.0000000000001991.

    Article  PubMed  Google Scholar 

  37. Scriven JE, Scobie A, Verlander NQ, Houston A, Collyns T, Cajic V, et al. Mycobacterium chimaera infection following cardiac surgery in the United Kingdom: clinical features and outcome of the first 30 cases. Clin Microbiol Infect. 2018;24:1164–70. https://doi.org/10.1016/j.cmi.2018.04.027.

    Article  CAS  PubMed  Google Scholar 

  38. Lau D, Cooper R, Chen J, Sim VL, McCombe JA, Tyrrell GJ, et al. Mycobacterium chimaera encephalitis following cardiac surgery: a new syndrome. Clin Infect Dis. 2019:ciz497. https://doi.org/10.1093/cid/ciz497.

  39. Kasperbauer SH, Daley CL. Mycobacterium chimaera infections related to the Heater–Cooler unit outbreak: a guide to diagnosis and management. Clin Infect Dis. 2019;68:1244–50. https://doi.org/10.1093/cid/ciy789.

    Article  CAS  PubMed  Google Scholar 

  40. Daley CL. Mycobacterium avium complex disease. Microbiol Spectr. 2017:5. https://doi.org/10.1128/microbiolspec.TNMI7-0045-2017.

  41. Winthrop KL, Marras TK, Adjemian J, Zhang H, Wang P, Zhang Q. Incidence and prevalence of nontuberculous mycobacterial lung disease in a large U.S. managed care health plan, 2008–2015. Ann Am Thorac Soc. 2020;17:178–85. https://doi.org/10.1513/AnnalsATS.201804-236OC.

    Article  PubMed  PubMed Central  Google Scholar 

  42. van Ingen J. Microbiological diagnosis of nontuberculous mycobacterial pulmonary disease. Clin Chest Med. 2015;36:43–54. https://doi.org/10.1016/j.ccm.2014.11.005.

    Article  PubMed  Google Scholar 

  43. Brown-Elliott BA, Philley JV. Rapidly growing mycobacteria. Microbiol Spectr. 2017:5. https://doi.org/10.1128/microbiolspec.TNMI7-0027-2016.

  44. Duarte RS, Lourenco MCS, Fonseca LDS, Leao SC, Amorim EDLT, Rocha ILL, et al. Epidemic of postsurgical infections caused by Mycobacterium massiliense. J Clin Microbiol. 2009;47:2149–55. https://doi.org/10.1128/JCM.00027-09.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Schnabel D, Gaines J, Nguyen DB, Esposito DH, Ridpath A, Yacisin K, et al. Rapidly growing nontuberculous mycobacterium wound infections among medical tourists undergoing cosmetic surgeries in the Dominican Republic—Multiple States, March 2013–February 2014. MMWR Morb Mortal Wkly Rep. 2014;63:201–2.

    PubMed  PubMed Central  Google Scholar 

  46. Perkins KM, Lawsin A, Hasan NA, Strong M, Halpin AL, Rodger RR, et al. Notes from the field : Mycobacterium chimaera contamination of heater-cooler devices used in cardiac surgery — United States. MMWR Morb Mortal Wkly Rep. 2016;65:1117–8. https://doi.org/10.15585/mmwr.mm6540a6.

    Article  PubMed  Google Scholar 

  47. Asadi T, Mullin K, Roselli E, Johnston D, Tan CD, Rodriguez ER, et al. Disseminated Mycobacterium chimaera infection associated with heater–cooler units after aortic valve surgery without endocarditis. J Thorac Cardiovasc Surg. 2018;155:2369–74. https://doi.org/10.1016/j.jtcvs.2017.12.049.

    Article  PubMed  Google Scholar 

  48. Kasperbauer SH, De Groote MA. The treatment of rapidly growing mycobacterial infections. Clin Chest Med. 2015;36:67–78. https://doi.org/10.1016/j.ccm.2014.10.004.

    Article  PubMed  Google Scholar 

  49. van Ingen J. Diagnosis of nontuberculous mycobacterial infections. Semin Respir Crit Care Med. 2013;34:103–9. https://doi.org/10.1055/s-0033-1333569.

    Article  PubMed  Google Scholar 

  50. Brown-Elliott BA, Nash KA, Wallace RJ. Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria. Clin Microbiol Rev. 2012;25:545–82. https://doi.org/10.1128/CMR.05030-11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Brown-Elliott BA, Woods GL. Antimycobacterial susceptibility testing of nontuberculous mycobacteria. J Clin Microbiol. 2019;57:e00834–19., /jcm/57/10/JCM.00834-19.atom. https://doi.org/10.1128/JCM.00834-19.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Wang M-S, Wang J-L, Wang X-F. The performance of interferon-gamma release assay in nontuberculous mycobacterial diseases: a retrospective study in China. BMC Pulm Med. 2016;16:163. https://doi.org/10.1186/s12890-016-0320-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Busin M, Ponzin D, Arffa RC. Mycobacterium chelonae interface infection after endokeratoplasty. Am J Ophthalmol. 2003;135:393–5. https://doi.org/10.1016/S0002-9394(02)01954-2.

    Article  PubMed  Google Scholar 

  54. Stewart MW, Alvarez S, Ginsburg WW, Shetty R, McLain WC, Sleater JP. Visual recovery following Mycobacterium chelonae endophthalmitis. Ocul Immunol Inflamm. 2006;14:181–3. https://doi.org/10.1080/09273940600678062.

    Article  PubMed  Google Scholar 

  55. Greendyke R, Byrd TF. Differential antibiotic susceptibility of Mycobacterium abscessus variants in biofilms and macrophages compared to that of planktonic bacteria. Antimicrob Agents Chemother. 2008;52:2019–26. https://doi.org/10.1128/AAC.00986-07.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Lee SH, Yoo HK, Kim SH, Koh W-J, Kim CK, Park YK, et al. The drug resistance profile of Mycobacterium abscessus group strains from Korea. Ann Lab Med. 2014;34:31–7. https://doi.org/10.3343/alm.2014.34.1.31.

    Article  PubMed  Google Scholar 

  57. Griffith D. Treatment of Mycobacterium avium complex (MAC). Semin Respir Crit Care Med. 2018;39:351–61. https://doi.org/10.1055/s-0038-1660472.

    Article  PubMed  Google Scholar 

  58. Philley JV, Griffith DE. Treatment of slowly growing mycobacteria. Clin Chest Med. 2015;36:79–90. https://doi.org/10.1016/j.ccm.2014.10.005.

    Article  PubMed  Google Scholar 

  59. Peloquin C. The role of therapeutic drug monitoring in mycobacterial infections. Microbiol Spectr. 2017:5. https://doi.org/10.1128/microbiolspec.TNMI7-0029-2016.

  60. Shulha JA, Escalante P, Wilson JW. Pharmacotherapy approaches in nontuberculous mycobacteria infections. Mayo Clin Proc. 2019;94:1567–81. https://doi.org/10.1016/j.mayocp.2018.12.011.

    Article  CAS  PubMed  Google Scholar 

  61. Egelund EF, Fennelly KP, Peloquin CA. Medications and monitoring in nontuberculous mycobacteria infections. Clin Chest Med. 2015;36:55–66. https://doi.org/10.1016/j.ccm.2014.11.001.

    Article  PubMed  Google Scholar 

  62. Kheir WJ, Sheheitli H, Abdul Fattah M, Hamam RN. Nontuberculous mycobacterial ocular infections: a systematic review of the literature. Biomed Res Int. 2015;2015:1–17. https://doi.org/10.1155/2015/164989.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arthi Venkat .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Zheng, A., Miranda, C., Venkat, A. (2023). Nontuberculous Mycobacterial Infections. In: Lowder, C.Y., Shrestha, N., Venkat, A. (eds) Emerging Ocular Infections. Essentials in Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-031-24559-6_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-24559-6_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-24558-9

  • Online ISBN: 978-3-031-24559-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics